Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19: A Randomized, Controlled Study CRI-CP (Coronavirus Investigation - Convalescent Plasma)

NCT04425837 is registered in ClinicalTrials.gov with Fundación Santa Fe de Bogota as lead sponsor.

NCT NCT04425837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04425837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19: A Randomized, Controlled Study CRI-CP (Coronavirus Investigation - Convalescent Plasma)
Lead sponsor
Fundación Santa Fe de Bogota
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2020
Completion date
February 28, 2021
Enrollment
236 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov2